Team Financial Group LLC Has $278,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Team Financial Group LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 547 shares of the healthcare conglomerate’s stock after purchasing an additional 21 shares during the quarter. UnitedHealth Group accounts for about 0.2% of Team Financial Group LLC’s investment portfolio, making the stock its 27th biggest holding. Team Financial Group LLC’s holdings in UnitedHealth Group were worth $278,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Aveo Capital Partners LLC raised its holdings in shares of UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after acquiring an additional 416 shares during the period. 9258 Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after purchasing an additional 290 shares in the last quarter. Gryphon Financial Partners LLC grew its holdings in shares of UnitedHealth Group by 80.9% during the fourth quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after buying an additional 2,782 shares in the last quarter. TrinityPoint Wealth LLC lifted its stake in UnitedHealth Group by 102.8% in the 4th quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after acquiring an additional 7,489 shares in the last quarter. Finally, ProVise Management Group LLC lifted its position in shares of UnitedHealth Group by 3.0% in the fourth quarter. ProVise Management Group LLC now owns 5,256 shares of the healthcare conglomerate’s stock worth $2,767,000 after purchasing an additional 155 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $575.00 on Friday. The stock has a market cap of $529.22 billion, a price-to-earnings ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company’s fifty day moving average is $577.10 and its 200 day moving average is $520.80.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $6.14 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on UNH shares. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. HSBC upped their price objective on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, September 17th. Finally, TD Cowen lifted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.